微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 17.2% | 7.7% | 107.48% | 6/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.29% | -19.51% | 21.2% | 15/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 6.84% | 42.2% | -46.85% | 3/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 12.87% | -5.51% | -19.41% | 18/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 15.97% | 20.62% | 55.05% | 5/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 10.3% | 13.44% | 114.14% | 6/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.81% | 35.11% | -64.68% | 11/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 13.62% | 70.68% | 2.87% | 23/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 13.24% | 61.66% | 45.81% | 18/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.08% | 75.29% | 155.06% | 16/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.56% | 90.37% | -55.39% | 25/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.98% | 91.37% | -2.56% | 58/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.19% | 70.98% | 58.11% | 52/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.18% | 175.53% | 177.01% | 55/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.87% | 59.83% | -55.16% | 72/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.17% | 5.04% | -12.94% | 92/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.79% | -1.84% | 154.79% | 73/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.88% | -34.27% | 60.68% | 89/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.17% | -47.77% | -70.53% | 67/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.97% | -29.23% | -18.65% | 97/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.88% | -32.5% | 70.63% | 69/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.86% | -33.95% | 27.68% | 76/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.24% | -41.67% | -60.07% | 51/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.61% | -50.92% | -22.41% | 81/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.23% | -47.15% | 66.97% | 45/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.33% | -58.68% | 12.76% | 50/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.84% | 2% | -66.4% | 18/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 11.43% | -48.49% | -16.45% | 44/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 13.68% | 2% | 30.53% | 16/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 10.48% | -15.82% | -52.77% | 15/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 22.19% | -31.58% | 78.23% | 16/160 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2016-06-30 | 12.45% | 2% | -61.61% | 6/160 | 3.53% | 华东医药 | 7.2% | 行业排名> |
| 2015-12-31 | 32.43% | 2% | 2% | 6/160 | 11.35% | 南新制药 | 81.7% | 行业排名> |